45 studies found for:    Open Studies | "Staphylococcal Infections"
Show Display Options
Rank Status Study
21 Recruiting Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP)
Condition: Cystic Fibrosis
Interventions: Drug: Inhaled Vancomycin;   Drug: Placebo (Sterile Water);   Drug: Rifampin;   Drug: Trimethoprim/Sulfamethoxazole (TMP/SMX);   Drug: Doxycycline;   Drug: Mupirocin Nasal Ointment;   Drug: 4% chlorhexidine gluconate liquid skin cleanser
22 Unknown  Randomized Controlled Trial of Antibiotics in the Management of Children With Community-Acquired Skin and Soft Tissue Abscess Undergoing Incision and Drainage
Conditions: Skin and Soft Tissue Abscess;   Methicillin-resistant Staphylococcus Aureus (MRSA) Infection
Intervention: Drug: Oral Clindamycin
23 Recruiting Retapamulin for Reducing MRSA Nasal Carriage
Condition: Methicillin-Resistant Staphylococcus Aureus
Interventions: Drug: Retapamulin;   Drug: Placebo
24 Recruiting Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization
Condition: Methicillin-resistant Staphylococcus Aureus
Interventions: Drug: Rifampin;   Drug: Doxycycline;   Other: 2% mupirocin ointment;   Other: 4% chlorhexidine gluconate
25 Unknown  Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
Condition: Methicillin Resistant Staphylococcus Aureus
Intervention:
26 Unknown  Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia
Conditions: Methicillin-resistant Staphylococcus Aureus;   Pneumonia, Ventilator-Associated
Intervention: Drug: Imipenem/cilastatin
27 Unknown  Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
Condition: Methicillin-resistant Staphylococcus Aureus
Intervention:
28 Unknown  A Pilot Trial to Determine the Efficacy of Lactobacillus Rhamnosus for Reducing Colonization by Methicillin-resistant Staphylococcus Aureus (MRSA) (PROSE)
Condition: Infection
Interventions: Dietary Supplement: Lactobacillus rhamnosus;   Dietary Supplement: Sugar pill (placebo)
29 Unknown  Incidence and Relationship of Positive Preoperative Methicillin Resistant Staphylococcus Aureus (MRSA) Screens and Post-operative Infections
Condition: Methicillin-resistant Staphylococcus Aureus Infection
Intervention: Other: Preoperative MRSA screening
30 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community-Healthcare Workers
Conditions: Methicillin-Resistant Staphylococcus Aureus;   ESBL
Intervention:
31 Unknown  Mastering Hospital Antimicrobial Resistance and Its Spread Into the Community
Conditions: ESBL Infection;   Methicillin-Resistant Staphylococcus Aureus
Intervention:
32 Unknown  Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns
Condition: Staphylococcus Aureus Infection
Intervention: Other: CA-MRSA Decolonization
33 Not yet recruiting Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess
Condition: Furunculosis
Intervention: Biological: Antimicrobial TheraGauze
34 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
35 Recruiting Study of the Efficacy and Safety of MEDI4893
Condition: Staphylococcus Aureus Pneumonia
Interventions: Drug: MEDI4893;   Other: Placebo
36 Recruiting Human Immunity Against Staphylococcus Aureus Skin Infection
Condition: Staphylococcus Aureus Skin Infection
Intervention: Other: Killed Bacteria
37 Recruiting Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo
Condition: Impetigo
Interventions: Drug: Ozenoxacin;   Drug: Placebo
38 Recruiting Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
39 Recruiting The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
Condition: Impetigo
Interventions: Drug: papaya 1% extract ointment;   Drug: mupirocin 2% ointment
40 Unknown  Citriodiol® and Impetigo
Condition: Impetigo
Intervention: Drug: p-menthane-3,8-diol oil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-45) Show next page of results    Last Page
Indicates status has not been verified in more than two years